Staphylococcus aureus bacteraemia - Nationwide assessment of treatment adequacy and outcome

Journal of Infection

Volumn 62, Issue 5, 2011, Pages 339-346

  Asgeirsson, Hilmir ^a   Kristjansson, Mar ^a   Kristinsson, Karl G ^a,b   Gudlaugsson, Olafur ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Bacteraemia; Mortality; Relapse; Staphylococcus aureus; Treatment

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLAVULANIC ACID; CLOXACILLIN; DAPTOMYCIN; OXACILLIN; PENICILLIN G; VANCOMYCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; ICELAND; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; FEMALE; HUMANS; ICELAND; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 79956127925     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.03.003     Document Type: Article

References (29)

1. Uslan D.Z., Crane S.J., Steckelberg J.M., Cockerill F.R., St Sauver J.L., Wilson W.R., et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med 2007, 167:834-839.
2. Benfield T., Espersen F., Frimodt-Møller N., Jensen A.G., Larsen A.R., Pallesen L.V., et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 2007, 13:257-263.
3. Lyytikäinen O., Ruotsalainen E., Järvinen A., Valtonen V., Ruutu P. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001. Eur J Clin Microbiol Infect Dis 2005, 24:399-404.
4. Laupland K.B., Ross T., Gregson D.B. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008, 198:336-343.
5. Chang F.Y., MacDonald B.B., Peacock J.E.J., Musher D.M., Triplett P., Mylotte J.M., et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 2003, 82:322-332.
6. Johnson L.B., Almoujahed M.O., Ilg K., Maolood L., Khatib R. Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse. Scand J Infect Dis 2003, 35:782-789.
7. Jensen A.G., Wachmann C.H., Espersen F., Scheibel J., Skinhøj P., Frimodt-Møller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 2002, 162:25-32.
8. Osmon S., Ward S., Fraser V.J., Kollef M.H. Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest 2004, 125:607-616.
9. Ammerlaan H., Seifert H., Harbarth S., Brun-Buisson C., Torres A., Antonelli M., et al. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis 2009, 49:997-1005.
10. Fätkenheuer G., Preuss M., Salzberger B., Schmeisser N., Cornely O.A., Wisplinghoff H., et al. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2004, 23:157-162.
11. Chang F.Y., Peacock J.E.J., Musher D.M., Triplett P., MacDonald B.B., Mylotte J.M., et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 2003, 82:333-339.
12. Thomas M.G., Morris A.J. Cannula-associated Staphylococcus aureus bacteraemia: outcome in relation to treatment. Intern Med J 2005, 35:319-330.
13. Verhagen D.W., van der Meer J.T., Hamming T., de Jong M.D., Speelman P. Management of patients with Staphylococcus aureus bacteraemia in a university hospital: a retrospective study. Scand J Infect Dis 2003, 35:459-463.
14. Zeylemaker M.M., Jaspers C.A., van Kraaij M.G., Visser M.R., Hoepelman I.M. Long-term infectious complications and their relation to treatment duration in catheter-related Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2001, 20:380-384.
15. Kim S.H., Park W.B., Lee C.S., Kang C.I., Bang J.W., Kim H.B., et al. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores. Clin Microbiol Infect 2006, 12:13-21.
16. Wang J.L., Chen S.Y., Wang J.T., Wu G.H., Chiang W.C., Hsueh P.R., et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008, 15:6.
17. Lodise T.P., McKinnon P.S., Swiderski L., Rybak M.J. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003, 36:1418-1423.
18. Melzer M., Eykyn S.J., Gransden W.R., Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? a comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 2003, 37:1453-1460.
19. Soriano A., Martínez J.A., Mensa J., Marco F., Almela M., Moreno-Martínez A., et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000, 30:368-373.
20. Rodríguez-Baño J., Millán A.B., Domínguez M.A., Borraz C., González M.P., Almirante B., et al. Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus. J Infect 2009, 58:131-137.
21. Price J., Baker G., Heath I., Walker-Bone K., Cubbon M., Curtis S., et al. Clinical and microbiological Determinants of outcome in Staphylococcus aureus bacteraemia. Int J Microbiol 2010, 2010:654858. Epub 2010 Mar 16.
22. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
23. Roghmann M.C. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 2000, 160:1001-1004.
24. Mylotte J.M., Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000, 31:1170-1174.
25. Schweizer M.L., Furuno J.P., Harris A.D., Johnson J.K., Shardell M.D., McGregor J.C., et al. Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study. PLoS One 2010, 5. e11432.
26. Laupland K.B., Church D.L., Mucenski M., Sutherland L.R., Davies H.D. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 2003, 187:1452-1459.
27. Kaech C., Elzi L., Sendi P., Frei R., Laifer G., Bassetti S., et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect 2006, 12:345-352.
28. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
29. Dombrovskiy V.Y., Martin A.A., Sunderram J., Paz H.L. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007, 35:1244-1250.